Amanote Research
Register
Sign In
Cediranib Is Effective in Alveolar Soft Part Sarcoma
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2013-098
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
May 9, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Faculty Opinions Recommendation of Cediranib for Metastatic Alveolar Soft Part Sarcoma.
Alveolar Soft Part Sarcoma
Alveolar Soft Part Sarcoma
Alveolar Soft-Part Sarcoma.
Thorax
Pulmonary
Respiratory Medicine
Alveolar Soft-Part Sarcoma of the Retroperitoneum
International Journal of Urology
Urology
Alveolar Soft Part Sarcoma: Clinicopathological Analysis and Imaging Results
Oncology Letters
Cancer Research
Oncology
Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Alveolar Soft Part Sarcoma: The New Primary Intracranial Malignancy
Neurosurgical Review
Medicine
Surgery
Neurology
A Case of Alveolar Soft Part Sarcoma in the Masseter
Practica Otologica, Supplement
Otorhinolaryngology